Prevacid
Product Images NDC 54868-5303

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Prevacid (NDC 54868-5303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (15 mg Capsules)

Label for Prevacid 15 mg distributed by Physicians Total Care, Inc. It includes the NDC 54868-3867-0, lot number 0000, and an expiration date of 01/60. The label also shows a barcode and manufacturing information from TUKAM PHARMACEUTICALS INC, Deerfield, IL 60015.*

FDA Label Image

Principal Display Panel (15 mg SoluTab)

Packaging label of Prevacid Solutab 15 mg, distributed by Physicians Total Care, Inc. The label features the product name, dosage strength, lot number, expiration date, and a barcode. The manufacturer is Takeda Pharmaceuticals USA, Deerfield, IL.*

FDA Label Image

Principal Display Panel (30 mg Capsules)

Packaging label for Prevacid delayed release capsules containing 30 mg of lansoprazole. The label specifies a quantity of 30 capsules and includes caution about prescription requirements. The labeler is Physicians Total Care, Inc. Additional details include lot number, expiration date, storage instructions, and usual dosage directions.*

FDA Label Image

Principal Display Panel (30 mg SoluTab)

Label for Prevacid Solutab 30 mg showing distribution by Physicians Total Care, Inc., listing NDC 54868-5303-0, lot number 0000, and an expiration date of 01/60. The label also indicates manufacturing by Takeda Pharmaceuticals America in Deerfield, IL, and includes a barcode with the number 53030300000.*

FDA Label Image

Chemical Structure (Prevacid 01)

Chemical structure of the active ingredient in Prevacid, showing a benzimidazole core linked to a sulfinylmethyl group and a substituted pyridine ring.*

FDA Label Image

Figure (Prevacid 02)

Line chart titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' showing mean severity scores over days from the start of treatment comparing Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups. Severity scale ranges from 0 (None) to 3 (Severe).*

FDA Label Image

Figure (Prevacid 03)

A line graph showing mean severity of night heartburn over approximately 60 days from start of treatment. It compares three groups: placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, with severity scored from 0 (none) to 3 (severe). Lansoprazole groups show a decrease in severity over time compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.